Network-guided TMS in Early Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 8, 2022

Primary Completion Date

June 27, 2025

Study Completion Date

June 27, 2025

Conditions
Mild Cognitive Impairment
Interventions
DEVICE

Transcranial Magnetic Stimulation

Transcranial magnetic stimulation (TMS) is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve a variety of cognitive conditions, and to probe the dynamics of normal brain function.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Duke University

OTHER

NCT04549155 - Network-guided TMS in Early Alzheimer's Disease | Biotech Hunter | Biotech Hunter